XML 20 R7.htm IDEA: XBRL DOCUMENT v3.25.3
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
 9 Months Ended
Sep. 30, 2025
Sep. 30, 2024
Cash flows from operating activities:    
Net income $ 9,802,000 $ 18,223,000
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation and amortization [1] 5,479,000 4,506,000
Deferred income taxes [1] (80,000) (118,000)
Reserve for uncertain tax positions [1] 103,000 211,000
Non-cash share-based compensation expense [1] 1,403,000 96,000
Change in fair value of contingent consideration [1] 131,000 23,000
Loss on extinguishment of debt 67,000 0
Amortization of debt issuance costs 75,000 29,000
Net changes in assets and liabilities:    
Trade accounts receivable (1,694,000) 1,752,000
Prepaid expenses and other current and noncurrent assets (1,021,000) 91,000
Deferred contract costs, net (359,000) 212,000
Operating lease assets and liabilities, net (40,000) 9,000
Accounts payable 66,000 599,000
Accrued expenses, wages and bonuses 2,146,000 1,760,000
Income taxes receivable and payable 1,246,000 (706,000)
Deferred revenue 1,947,000 1,559,000
Net cash provided by operating activities 19,271,000 28,246,000
Cash flows from investing activities:    
Purchases of property and equipment (9,585,000) (11,004,000)
Acquisitions, net of cash acquired (0) 4,833,000
Net cash used in investing activities (9,585,000) (15,837,000)
Cash flows from financing activities:    
Borrowings on notes payable 47,681,000 17,000,000
Payments on notes payable (30,393,000) (5,044,000)
Borrowings on revolving loan 33,000,000 39,000,000
Payments on revolving loan (33,003,000) (34,000,000)
Payment of debt issuance costs (135,000) (37,000)
Payments on finance lease obligations (7,000) (19,000)
Proceeds from the exercise of share-based awards 132,000 0
Payment of payroll tax withholdings on share-based awards exercised 0 (317,000)
Payment of acquisition contingent consideration (516,000) 0
Repurchase of shares for treasury (20,179,000) (23,548,000)
Payment of dividends on common stock (8,280,000) (8,636,000)
Net cash used in financing activities (11,700,000) (15,601,000)
Change in cash and cash equivalents (2,014,000) (3,192,000)
Cash and cash equivalents at beginning of period 4,233,000 6,653,000
Cash and cash equivalents at end of period 2,219,000 3,461,000
Supplemental disclosure of cash paid for:    
Interest expense, net of capitalized amounts 3,124,000 1,699,000
Income taxes 3,529,000 6,270,000
Supplemental disclosure of non-cash investing and financing activities:    
Stock tendered to the Company for cashless exercise of stock options in connection with equity incentive plans 0 1,752,000
Purchase of property and equipment in accounts payable and accrued expenses 298,000 2,610,000
Repurchase of shares for treasury in accounts payable and accrued expenses 230,000 238,000
Debt extinguished with new debt 34,396,000 0
Noncash borrowings on long-term debt for accrued interest and debt issuance costs 351,000 0
Contingent consideration recorded in connection with acquisition $ 0 $ 776,000
[1] Other significant expenses are also included within the team expenses captions such as associate and other operating expenses.